Cited by 106Metabolism and Genetic DisordersCancer, Hypoxia, and MetabolismCancer, Lipids, and Metabolism

Metabolic dysregulation in monogenic disorders and cancer — finding method in madness

Erez, Ayelet, DeBerardinis, Ralph J.·2015·Nature Reviews Cancer

Abstract

Cancer is a prime example of a disease process in which carcinogenic and metabolic changes are intertwined to promote cell survival and growth. One approach to unravel this complex relationship is by studying rare, monogenic disorders caused by mutations in genes encoding metabolic enzymes or regulators. There are hundreds of these diseases, most of which manifest in childhood and are collectively termed 'inborn errors of metabolism' (IEMs). Several IEMs demonstrate the consequences of chronic, systemic loss of a particular metabolic activity that can result in malignancy. In this Opinion article, we present a conceptual categorization of IEMs associated with cancer and discuss how assessment of these rare diseases might inform us about the biological foundations of common types of cancer and opportunities for cancer diagnosis and therapy.

Integrity signals

Registry

Crossref · 10.1038/nrc3949

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cancers arising from inborn errors of metabolism, with biallelic germline mutations in metabolic enzymes, are restricted to a subset of tissues specific for each enzyme.

    “Other cancers arise from inborn errors of metabolism, in which biallelic germline mutations in metabolic enzymes cause a widespread failure of metabolic homeostasis, but cancer is restricted to a subset of tissues specific for each enzyme (12).”

    From Metabolic reprogramming and cancer progression (2020) · cites this paper as [12]

  • In mammals, disrupting TCA cycle function causes inborn errors of metabolism due to inherited mutations in genes encoding metabolic enzymes.

    “In mammals, the consequences of disrupting TCA cycle function can be found in a group of disorders known as inborn errors of metabolism, which are caused by inherited mutations in genes encoding metabolic enzymes.”
  • Human patients with mutations in TCA cycle-associated genes display neonatal symptoms, developmental defects, and failure to thrive.

    “Human patients who present with mutations in TCA cycle–associated genes display neonatal symptoms, developmental defects, and failure to thrive (9, 10).”

Cites

1 retracted

Flagged first, then by citations

1 of the 127 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Erez, A., & DeBerardinis, R. J.
Affiliations
  • Weizmann Institute of Science (IL)
  • Children's Medical Center (US)
Corresponding author
  • Erez, Ayelet
  • DeBerardinis, Ralph J.
Venue
Nature Reviews Cancer
Published
2015-06-18
Volume
15
Issue
7
Pages
440-448
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W1541421641
Cited by
105
References
127
Citations by year
2026: 2 · 2025: 5 · 2024: 7 · 2023: 12 · 2022: 13 · 2021: 13 · 2020: 10 · 2019: 18 · 2018: 9 · 2017: 7 · 2016: 8 · 2015: 1
FWCI
0.86
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (CA157996, R01CA157996)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
inborn errors of metabolism, monogenic disorders, metabolic dysfunction, cancer, metabolic enzymes, metabolic modulators, cancer susceptibility, cancer diagnosis, cancer therapy, rare diseases, carcinogenesis
MeSH terms
Animals, Glycolysis, Humans, Isocitrate Dehydrogenase, Metabolism, Inborn Errors, Neoplasms, Phosphoglycerate Dehydrogenase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review